SC 13G Filing

Company

Aldeyra Therapeutics, Inc.

Filed

May 13, 2015

Accession Number

0001193805-15-000722

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →